ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.

With regards to the question of differential toxicity, although there was an excess of grade 1 nausea and vomiting in cycles that commenced with oral ATO, that difference did not reach statistical significance.

also in 111,027 other papers